Filing Flows › Industries › Electromedical & Electrotherapeutic Apparatus › Capital spending and supply chain
Electromedical & Electrotherapeutic Apparatus: capital spending and supply chain
SIC 3845 · 17 companies with filed cash-flow statements
Analysis
17 companies in Electromedical & Electrotherapeutic Apparatus (SIC 3845) spent $2.2B on capital projects over their latest twelve months, 26% of the $8.5B their operations generated; the three largest spenders — MDT, LIVN, ITGR — account for 96%.
Capital spending is 5.0% of the industry's $44.0B of annual revenue.
By the industry's asset mix most of it goes to equipment (44%); about $479M is imported.
The largest supplier of that spending is manufacturing structures ($467M).
Its largest supplying industries, by the input-output tables: imports ($2.6B), professional and commercial equipment and supplies ($1.4B), plastics packaging materials and unlaminated film and sheet manufacturing ($977M).
Charts
Capital spending by company
| Company | Capital spending | Operating cash flow | Capex / OCF | Period |
|---|---|---|---|---|
| MDT Medtronic | $1.9B | $8.0B | 24% | TTM to Q1 FY27 |
| LIVN LivaNova | $109M | $238M | 46% | TTM to Q3 2026 |
| ITGR Integer Holdings | $94.7M | $176M | 54% | TTM to Q3 2026 |
| TMDX TransMedics Group | $67.7M | $112M | 60% | TTM to Q3 2026 |
| CNMD Conmed | $13.6M | $146M | 9% | TTM to Q3 2026 |
| BLFS Biolife Solutions | $8.8M | $16.9M | 52% | TTM to Q2 2026 |
| AXGN Axogen | $6.3M | $28.4M | 22% | TTM to Q3 2026 |
| OM Outset Medical | $508K | −$42.4M | — | TTM to Q3 2026 |
| HYPR Hyperfine | $465K | −$27.1M | — | TTM to Q2 2026 |
| CBLL Ceribell | $421K | −$56.0M | — | TTM to Q3 2026 |
| IRIX Iridex | $270K | −$1.7M | — | TTM to Q2 2026 |
| QTI QT Imaging Holdings | $268K | −$12.5M | — | TTM to Q2 2026 |
| STXS Stereotaxis | $213K | −$15.3M | — | TTM to Q2 2026 |
| NUWE Nuwellis | $125K | −$12.5M | — | TTM to Q2 2026 |
| CV CapsoVision | $68K | −$27.8M | — | TTM to Q2 2026 |
| NRXS Neuraxis | $12K | −$5.6M | — | TTM to Q2 2026 |
| ECOR electroCore | $6K | −$10.9M | — | TTM to Q3 2026 |
Customers and suppliers named in annual reports
| Supplier | Customer | Share of supplier revenue | Evidence | Source |
|---|---|---|---|---|
| ITGR | BSX | 49% | Stated in 10-K (sentence) | filing |
| ITGR | ABT | 10% | Stated in 10-K (sentence) | filing |
| ADMT | ZOMDF | — | Stated in 10-K (named, share not stated) | filing |
| BHE | HYPR | — | Stated in 10-K (named, share not stated) | filing |
The interactive money flow: switch views, follow each dollar →
Evidence grades: A filed figure · B computed from filed figures · C industry average (BEA input-output and fixed-asset tables) applied to filed figures. Estimates are not the companies’ own records. Not investment advice.